XTrackers MSCI China UCITS ETF 1C

Issuer: Xtrackers
Asset Class: Equity
TER: 65bps
Trading Currency: USD
Pays Income: False
Listing Date: 12 Nov 2010
Ticker: XCS6
ISIN: LU0514695690
This fund offers targeted exposure to the Chinese equity market by tracking a major benchmark index. It provides a comprehensive way to invest in the second-largest economy in the world, capturing a wide array of large and mid-capitalization Chinese companies. The portfolio is tilted towards key sectors driving China's modern economy, such as consumer discretionary, communication services, and financials. This composition allows investors to participate in the growth of leading Chinese technology giants, e-commerce platforms, and major financial institutions, which form the core of the underlying index.

Investing in the Chinese market presents a significant growth opportunity, driven by domestic consumption, technological innovation, and ongoing economic reforms. The country's expanding middle class continues to fuel demand for goods and services, benefiting many of the companies held within the portfolio. However, investors should be aware of the inherent risks. These include regulatory changes from the Chinese government, which can significantly impact specific industries, particularly technology and education. Geopolitical tensions and macroeconomic uncertainties also pose potential challenges. The concentrated country exposure means that the fund's performance is highly dependent on the economic and political climate within China.

This product is suitable for investors seeking long-term capital growth who have a higher risk tolerance and wish to add specific emerging market exposure to their portfolio. It can serve as a core holding for a China-centric strategy or as a tactical allocation to capitalize on the country's economic trends. The physical replication method ensures direct ownership of the underlying stocks, providing transparency. Given the volatility associated with single-country emerging market investing, a thorough evaluation of personal risk appetite and investment horizon is recommended before allocating capital.

Other Exchange Listings